These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Applying the genome to national drug formulary policy in the developing world. Roederer MW; McLeod HL Pharmacogenomics; 2010 May; 11(5):633-6. PubMed ID: 20415551 [TBL] [Abstract][Full Text] [Related]
25. Germline pharmacogenetics of paclitaxel for cancer treatment. Hertz DL Pharmacogenomics; 2013 Jul; 14(9):1065-84. PubMed ID: 23837481 [TBL] [Abstract][Full Text] [Related]
26. On the value of haplotype-based genotype-phenotype analysis and on data transformation in pharmacogenetics and -genomics. Vormfelde SV; Brockmöller J Nat Rev Genet; 2007 Dec; 8(12):. PubMed ID: 19066603 [No Abstract] [Full Text] [Related]
27. [Pharmacogenetics: current state after 30 years of research]. Eichelbaum M Dtsch Med Wochenschr; 2013 Mar; 138(13):659-61. PubMed ID: 23512369 [No Abstract] [Full Text] [Related]
29. [Goals of pharmacogenetics for predetermined therapy. With genetic record to the doctor]. Eiden P MMW Fortschr Med; 2000 Aug; 142(31-32):4-6. PubMed ID: 10992758 [No Abstract] [Full Text] [Related]
30. CYP450 pharmacogenetics for personalizing cancer therapy. van Schaik RH Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526 [TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy. Ansari M; Krajinovic M Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657 [TBL] [Abstract][Full Text] [Related]
35. Germline genetic variation, cancer outcome, and pharmacogenetics. Coate L; Cuffe S; Horgan A; Hung RJ; Christiani D; Liu G J Clin Oncol; 2010 Sep; 28(26):4029-37. PubMed ID: 20679599 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics. Going from genome to pill. Service RF Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283 [No Abstract] [Full Text] [Related]
37. Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy. Savonarola A; Palmirotta R; Guadagni F; Silvestris F Pharmacogenomics J; 2012 Aug; 12(4):277-86. PubMed ID: 22760589 [TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic considerations for late life depression therapy. Pitychoutis PM; Kokras N; Sanoudou D; Dalla C; Papadopoulou-Daifoti Z Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):989-99. PubMed ID: 23641676 [TBL] [Abstract][Full Text] [Related]
39. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model. Goetz MP; Ames MM; Weinshilboum RM Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610 [TBL] [Abstract][Full Text] [Related]
40. [Pharmacogenetics and tailored drug therapy]. Nielsen FC; Borregaard N Ugeskr Laeger; 2009 Mar; 171(10):790-4. PubMed ID: 19265602 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]